Global Vaccines Market Size, Share, Growth & Trends Report Segmented by Vaccine Type (Recombinant, Conjugate, Inactivated, mRNA), Route of Administration (Oral, Parenteral, Nasal), Disease Type (Viral, Bacterial, Cancer), Age and Distribution Channel, & Regional Forecast to 2031

1. Introduction
   • Introduction​
   • Market Scope​
     • Market Definition​
     • Segments Covered​
     • Regional Segmentation​
   • Research Timeframe​
   • Currency Considered​
   • Study Limitations​
   • Stakeholders​
   • List of Abbreviations​
   • Key Conferences and Events (2026-2027)​
2. Research Methodology​
   • Secondary Research​
   • Primary Research​
   • Market Estimation​
     • Bottom-Up Approach​
     • Top-Down Approach​
   • Market Forecasting​
3. Executive Summary
   • Vaccines Market Snapshot (2026-2031)​
   • Segment Overview​
   • Regional Snapshot​
   • Competitive Insights ​

4. Market Overview
   • Market Dynamics
     • Drivers
       • Rising prevalence of infectious diseases
       • Increased government funding and immunization programs
       • Advancements in vaccine technologies
       • Growing public awareness about vaccine benefits
       • Rise in pharmaceutical R&D investment
     • Restraints​
       • High costs associated with vaccine R&D
       • Stringent regulatory approval processes
       • Limited healthcare infrastructure in certain regions  
     • Opportunities​
       • Growth in adult vaccination markets
       • Expansion of contract manufacturing
       • Increasing partnerships between governments and biotech firms
       • Expanding vaccine access in emerging markets
     • Key Market Trends
       • mRNA vaccine technology expansion beyond COVID-19
       • Growth in digital health solutions for vaccine tracking and management
     • Unmet Market Needs​
     • Industry Speaks​

5. Global Vaccines Market Size & Forecast (2024-2031), By Vaccine Type, USD Billion
   • Introduction​
   • Recombinant Vaccines
   • Conjugate Vaccines
   • Inactivated
   • Live Attenuated
   • Viral Vector Vaccines
   • mRNA Vaccines
   • Others

6. Global Vaccines Market Size & Forecast (2024-2031), By Route of Administration, USD Billion
   • Introduction​
   • Oral
   • Parenteral
   • Nasal

7. Global Vaccines Market Size & Forecast (2024-2031), By Disease Type, USD Billion
   • Introduction
   • Viral Diseases
     • Hepatitis
     • Influenza
     • HPV
     • MMR
     • Rotavirus
     • Herpes Zoster
     • Covid-19
     • Others
   • Bacterial Vaccines
     • Meningococcal Diseases
     • Pneumococcal diseases
     • DPT
     • Others
   • Cancer Vaccines
   • Allergy Vaccines
   • Others

8. Global Vaccines Market Size & Forecast (2024-2031), By Age, USD Billion​
   • Introduction​
   • Paediatric
   • Adult

9. Global Vaccines Market Size & Forecast (2024-2031), By Distribution Channel, USD Billion​
   • Introduction​
   • Hospitals
   • Retail Pharmacies
   • Government Suppliers
   • Others

10. Global Vaccines Market Size & Forecast (2024-2031), By Region, USD Billion
    • Introduction​
      • North America Vaccines Market Size & Forecast (2024-2031), By Country, USD Billion​
        • US​
          • Market Size & Forecast, By Vaccine Type (USD Billion)​
          • Market Size & Forecast, By Route of Administration (USD Billion)​
          • Market Size & Forecast, By Disease Type (USD Billion)​
          • Market Size & Forecast, By Age (USD Billion)​
          • Market Size & Forecast, By Distribution Channel (USD Billion)​
      • Canada​
        • Market Size & Forecast, By Vaccine Type (USD Billion)​
        • Market Size & Forecast, By Route of Administration (USD Billion)​
        • Market Size & Forecast, By Disease Type (USD Billion)​
        • Market Size & Forecast, By Age (USD Billion)​
        • Market Size & Forecast, By Distribution Channel (USD Billion)​
      • Europe Vaccines Market Size & Forecast (2024-2031), By Country, USD Billion​
        • UK ​
          • Market Size & Forecast, By Vaccine Type (USD Billion)​
          • Market Size & Forecast, By Route of Administration (USD Billion)​
          • Market Size & Forecast, By Disease Type (USD Billion)​
          • Market Size & Forecast, By Age (USD Billion)​
          • Market Size & Forecast, By Distribution Channel (USD Billion)​
        • Germany ​
          • Market Size & Forecast, By Vaccine Type (USD Billion)​
          • Market Size & Forecast, By Route of Administration (USD Billion)​
          • Market Size & Forecast, By Disease Type (USD Billion)​
          • Market Size & Forecast, By Age (USD Billion)​
          • Market Size & Forecast, By Distribution Channel (USD Billion)​
        • France ​
          • Market Size & Forecast, By Vaccine Type (USD Billion)​
          • Market Size & Forecast, By Route of Administration (USD Billion)​
          • Market Size & Forecast, By Disease Type (USD Billion)​
          • Market Size & Forecast, By Age (USD Billion)​
          • Market Size & Forecast, By Distribution Channel (USD Billion)​
        • Italy ​
          • Market Size & Forecast, By Vaccine Type (USD Billion)​
          • Market Size & Forecast, By Route of Administration (USD Billion)​
          • Market Size & Forecast, By Disease Type (USD Billion)​
          • Market Size & Forecast, By Age (USD Billion)​
          • Market Size & Forecast, By Distribution Channel (USD Billion)​
        • Spain ​
          • Market Size & Forecast, By Vaccine Type (USD Billion)​
          • Market Size & Forecast, By Route of Administration (USD Billion)​
          • Market Size & Forecast, By Disease Type (USD Billion)​
          • Market Size & Forecast, By Age (USD Billion)​
          • Market Size & Forecast, By Distribution Channel (USD Billion)​
        • Rest of Europe ​
          • Market Size & Forecast, By Vaccine Type (USD Billion)​
          • Market Size & Forecast, By Route of Administration (USD Billion)​
          • Market Size & Forecast, By Disease Type (USD Billion)​
          • Market Size & Forecast, By Age (USD Billion)​
          • Market Size & Forecast, By Distribution Channel (USD Billion)​
      • Asia Pacific (APAC) Vaccines Market Size & Forecast (2024-2031), By Country, USD Billion​
        • China ​
          • Market Size & Forecast, By Vaccine Type (USD Billion)​
          • Market Size & Forecast, By Route of Administration (USD Billion)​
          • Market Size & Forecast, By Disease Type (USD Billion)​
          • Market Size & Forecast, By Age (USD Billion)​
          • Market Size & Forecast, By Distribution Channel (USD Billion)​
        • Japan ​
          • Market Size & Forecast, By Vaccine Type (USD Billion)​
          • Market Size & Forecast, By Route of Administration (USD Billion)​
          • Market Size & Forecast, By Disease Type (USD Billion)​
          • Market Size & Forecast, By Age (USD Billion)​
          • Market Size & Forecast, By Distribution Channel (USD Billion)​​
        • India ​
          • Market Size & Forecast, By Vaccine Type (USD Billion)​
          • Market Size & Forecast, By Route of Administration (USD Billion)​
          • Market Size & Forecast, By Disease Type (USD Billion)​
          • Market Size & Forecast, By Age (USD Billion)​
          • Market Size & Forecast, By Distribution Channel (USD Billion)​
        • Rest of Asia Pacific ​
          • Market Size & Forecast, By Vaccine Type (USD Billion)​
          • Market Size & Forecast, By Route of Administration (USD Billion)​
          • Market Size & Forecast, By Disease Type (USD Billion)​
          • Market Size & Forecast, By Age (USD Billion)​
          • Market Size & Forecast, By Distribution Channel (USD Billion)​
      • Latin America (LATAM) Vaccines Market Size & Forecast (2024-2031), USD Billion​
        • Market Size & Forecast, By Vaccine Type (USD Billion)​
        • Market Size & Forecast, By Route of Administration (USD Billion)​
        • Market Size & Forecast, By Disease Type (USD Billion)​
        • Market Size & Forecast, By Age (USD Billion)​
        • Market Size & Forecast, By Distribution Channel (USD Billion)​
      • Middle East & Africa (MEA) Vaccines Market Size & Forecast (2024-2031), USD Billion​
        • Market Size & Forecast, By Vaccine Type (USD Billion)​
        • Market Size & Forecast, By Route of Administration (USD Billion)​
        • Market Size & Forecast, By Disease Type (USD Billion)​
        • Market Size & Forecast, By Age (USD Billion)​
        • Market Size & Forecast, By Distribution Channel (USD Billion)​

11. Competitive Landscape
    • Key Players and their Competitive Positioning
      • Key Player Comparison
      • Segment-wise Player Mapping
      • Market Share Analysis (2025)
      • Company Categorization Matrix
        • Dominants/Leaders
        • New Entrants
        • Emerging Players
        • Innovative Players
    • Key Strategies Assessment, By Player (2023-2026)
      • New Product Launch
      • Partnerships, Agreements, & Collaborations
      • Mergers & Acquisitions
      • Geographic Expansion

12. Company Profiles*

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

• Merck & Co. Inc.
• Pfizer Inc.
• Moderna Inc.
• CLS Seqirus
• Sanofi SA
• GSK Plc.
• Sinovac Biotech Ltd. 
• BioNTech SE
• AstraZeneca
• Serum Institute of India Pvt. Ltd.
• Emergent BioSolutions Inc.
• Other Prominent Players

Note: *Indicative list

**For listed companies